Drug Type CAR-NK |
Synonyms PRAME TCR-NK cell therapy(Replay) |
Target |
Action modulators |
Mechanism PRAME modulators(PRAME nuclear receptor transcriptional regulator modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | United States | 18 Dec 2023 |